GTC Biotherapeutics (fka GTCB)

[goatfondler]

you are absolutely right and I acknowledge that. But so far has it worked? No. Why is it with an approved drug and an amazing technology to produce proteins in a more economical fashion that the street has yet to recognize this? All that was said today is of no use if the Street doesn't know or care about it. Why is it that the major brokerage firms aren't there at the CC inquiring about this wonderful technology? I believe they were there back when GTCB was offered and probably most where there when it spiked up to 50 back in early 2000 and then deflated. Did GTCB promise too much back then? Is there something brewing behind the scenes that is keeping this stock at a price lower than after it had it's rejection of Atryn?

I believe that GTCB has a ton of potential. I am just not persuaded that management has the ability to build shareholder value as they haven't yet shown they can. The proof is in the share price and loss of shareholder value over the year in light of European approval and various deals.